The Johnson & Johnson Medical Devices Companies (JJMDC) will form a strategic partnership with Microsoft to further enhance and broaden its digital surgery ecosystem.

Under the partnership, Microsoft will serve as the preferred Cloud provider for JJMDC’s digital surgery solutions.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The collaboration with Microsoft will also allow JJMDC to expand its digital surgery platform and Internet of Things (IoT) device connectivity. 

With a focus on advancing skills, enhancing workflows and improving surgical decision making, JJMDC will leverage the Microsoft Cloud technologies, including Azure, artificial intelligence (AI) and machine learning, as well as Dynamics 365 and Microsoft 365 to accelerate its innovations.

Johnson & Johnson medical devices group CIO and global vice-president Larry Jones said: “Collaborating with Microsoft will help take our digital approach to the next level as we create a best-in-class, unified platform across our innovative surgical technologies.

“It brings together our collective expertise and is an exciting step towards creating a connected patient journey across the entire care continuum, before, during and after a procedure.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

As part of the collaboration, the companies will work together to improve patient outcomes with AI, machine learning and data insights.

The partnership will also utilise Azure IoT and Edge Computing technologies to scale-up JJMDC device connectivity, insights and intelligence.

Furthermore, by leveraging Azure capabilities and services, the companies will seek to accelerate digital innovation pace and transformation across the digital surgery ecosystem of JJMDC.

JJMDC medical affairs, clinical affairs and pre-clinical research global head and office of digital innovation leader Peter Schulam said: “We’re excited to collaborate with Microsoft on this important work as we continue to expand our digital surgery assets and capabilities, develop innovative and advanced instrumentation, and make a meaningful clinical difference for customers and patients.”

Last February, Activ Surgical was named the newest member of the Microsoft for Startups programme, through which the company got exclusive access to Microsoft’s technologies, including Azure.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact